Wall Street Journal - Sept 10
Sept 10 (Reuters) -The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
- China-based biotech company WuXi AppTec 603259.SS and its affiliate said they don't pose any security risk to the U.S. or other nations after the U.S. House of Representatives passed a draft Biosecure Act.
- Norfolk Southern NSC.N Chief Executive Alan Shaw is expected to depart the company as soon as this week amid a board investigation.
- Activist investor Starboard Value said News Corp NWSA.O should eliminate its dual-class share structure, saying it gives too much influence to the family of Rupert Murdoch.
- Drugmaker Eli Lilly named Lucas Montarce as chief financial officer, filling a vacancy left by the departure of Anat Ashkenazi, who joined Google's parent company Alphabet GOOGL.O as CFO earlier this year.
- Angela Zepeda, until recently the top marketer at Hyundai Motor America, will become the new global head of marketing at social-media platform X Corp.
(Compiled by Bengaluru newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
